Sign inCreate account

Report workspace tools

NCT03739736UNKNOWNanonymous

Tuberculosis Reduction Through Expanded Anti-retroviral Therapy and Screening of Active TB Project

Sponsor

Source record

London School of Hygiene and Tropical Medicine

Phase

Source record

Phase 3

Modality

AI-normalized

combination therapy

Target

AI-normalized

Tuberculosis (TB) and HIV co-infection

Indication / condition

AI-normalized

Tuberculosis

Intervention

Source record

Combination of TB/HIV prevention activities (arm A), Combination of TB/HIV prevention activities (arm B), Standard of care (arm C)

Source & freshness

Source record

NCT ID

NCT03739736

Original source

ClinicalTrials.gov

Source last updated

Feb 25, 2021

Ingested at

May 23, 2026

Internal sync

Jun 05, 2026

Model version

trialsignal-ai-v1

Normalized confidence

88%

Validation status

validated

Open original registry record
View original source fields

NCT ID

NCT03739736

Title

Tuberculosis Reduction Through Expanded Anti-retroviral Therapy and Screening of Active TB Project

Sponsor

London School of Hygiene and Tropical Medicine

Status

UNKNOWN

Phase

Phase 3

Condition raw

Tuberculosis

Condition normalized

Tuberculosis

Modality raw

Tuberculosis

Modality normalized

combination therapy

Target raw

Tuberculosis (TB) and HIV co-infection

Target normalized

Tuberculosis (TB) and HIV co-infection

Interventions

Combination of TB/HIV prevention activities (arm A), Combination of TB/HIV prevention activities (arm B), Standard of care (arm C)

Public preview

Source record

The TREATS project aims to evaluate the impact of a combined TB/HIV intervention on TB incidence and prevalence in communities in Zambia and South Africa. It builds on the HPTN 071 (PopART) trial, focusing on population-level screening for TB and universal testing and treatment for HIV. The project seeks to provide definitive evidence for public health policy on TB control and prevention strategies.

AI-generated analysis supports research triage only. Verify source records, publications, sponsor disclosures and IP databases before making diligence decisions. Model: trialsignal-ai-v1.

Report access

Create an account to unlock this report

Choose the access model that matches the job: one urgent report, reusable credits for project work, or unlimited monthly access with AI and folders.

Full protocol, outcomes, eligibility, contacts and results sections
Patent/IP landscape with verified records when available
Board-ready PDF export with source provenance
Save to folders and synthesize multiple assets in premium workspace
Create account
Sign in

Create a free account first, then unlock a single report, buy credits or subscribe.

TrialSignal

Clinical trial intelligence report

Tuberculosis Reduction Through Expanded Anti-retroviral Therapy and Screening of Active TB Project

Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.

Generated

Jun 13, 2026

NCT ID

NCT03739736

Status

UNKNOWN

Phase

Phase 3

Sponsor

London School of Hygiene and Tropical Medicine

Executive brief

Investment-Ready Snapshot

The TREATS project aims to evaluate the impact of a combined TB/HIV intervention on TB incidence and prevalence in communities in Zambia and South Africa. It builds on the HPTN 071 (PopART) trial, focusing on population-level screening for TB and universal testing and treatment for HIV. The project seeks to provide definitive evidence for public health policy on TB control and prevention strategies.

Source & freshness

Provenance

SourceClinicalTrials.gov
Source updatedFeb 25, 2021
Internal syncJun 05, 2026
Model versiontrialsignal-ai-v1

https://clinicaltrials.gov/study/NCT03739736

Indication

Tuberculosis

Modality

combination therapy

Target

Tuberculosis (TB) and HIV co-infection

Intervention

Combination of TB/HIV prevention activities (arm A), Combination of TB/HIV prevention activities (arm B), Standard of care (arm C)

Source record

Protocol Description

Detailed source ingestion pending.

Source record

Outcome Measures

Detailed source ingestion pending.

Source record

Eligibility

Detailed source ingestion pending.

AI analysis

Known Results And Readout Context

Detailed source ingestion pending.

IP intelligence

Patent And IP Landscape

Detailed source ingestion pending.

Source record

Contacts

Detailed source ingestion pending.